PRS2 A COST-MINIMIZATION ANALYSIS COMPARING MOXIFLOXACIN VERSUS LEVOFLOXACIN AND CEFTRIAXONE FOR THE TREATMENT OF PATIENTS HOSPITALIZED WITH COMMUNITY-ACQUIRED PNEUMONIA- RESULTS FROM THE MOTIVTRIAL
Nov 1, 2007, 00:00
10.1016/S1098-3015(10)65112-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)65112-1/fulltext
Title :
PRS2 A COST-MINIMIZATION ANALYSIS COMPARING MOXIFLOXACIN VERSUS LEVOFLOXACIN AND CEFTRIAXONE FOR THE TREATMENT OF PATIENTS HOSPITALIZED WITH COMMUNITY-ACQUIRED PNEUMONIA- RESULTS FROM THE MOTIVTRIAL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65112-1&doi=10.1016/S1098-3015(10)65112-1
First page :
Section Title :
Open access? :
No
Section Order :
273